Overview

Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a

Status:
Completed
Trial end date:
2018-07-18
Target enrollment:
Participant gender:
Summary
Improvement of the treatment-results in elderly patients with acute myeloid leukemia through intensification of consolidation chemotherapy and/or allografting as consolidative immunotherapy
Phase:
Phase 3
Details
Lead Sponsor:
University of Leipzig
Treatments:
Cytarabine